Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration

Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration. Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D.. Bone Marrow Transplant. 2016; 1265-7: p.1265-7. doi:10.1038/bmt.2016.109 10.1038/bmt.2016.109. Epub 2016 Apr 25.

Article